Eurizon Capital SGR S.p.A. Makes New Investment in Cardinal Health, Inc. $CAH

Eurizon Capital SGR S.p.A. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, Holdings Channel reports. The institutional investor bought 80,940 shares of the company’s stock, valued at approximately $16,637,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Strategy Asset Managers LLC acquired a new stake in shares of Cardinal Health during the third quarter worth $775,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Cardinal Health by 15.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock worth $5,938,000 after purchasing an additional 5,030 shares during the period. Versor Investments LP acquired a new stake in shares of Cardinal Health during the third quarter worth $2,090,000. Machina Capital S.A.S. raised its holdings in shares of Cardinal Health by 248.0% during the third quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock worth $4,246,000 after purchasing an additional 19,280 shares during the period. Finally, Atle Fund Management AB increased its holdings in shares of Cardinal Health by 13.1% in the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after acquiring an additional 3,500 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently weighed in on CAH shares. Morgan Stanley lifted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Wells Fargo & Company cut their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. TD Cowen lifted their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. cut their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Stock Down 0.1%

Shares of NYSE:CAH opened at $196.57 on Monday. The company has a market cap of $46.04 billion, a PE ratio of 30.06, a P/E/G ratio of 1.17 and a beta of 0.52. The company’s 50-day moving average price is $203.52 and its 200 day moving average price is $208.81. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.